KLRA+SD urged DBKL to publish the budget survey’s guidelines by Dec 31 and establish a timetable for consultations, decisions, spending approval and project outcomes. A residents’ group has called on ...

Vertex's strategy is simple. The company develops innovative medicines for diseases with high unmet needs, particularly (though not always) rare conditions. There are advantages and disadvantages to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal for Crinetics ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

Vertex offers $85 per Crinetics share, a 102% premium to stock's Monday close Deal gives access to Palsonify, an FDA-approved oral pill for adult acromegaly Vertex expects deal to become accretive to ...

Becker's Hospital Review Newsletter is sent Monday–Sunday.

Vertex stock skidded Tuesday on a mixed first-quarter report, but analysts remained more interested in the company's near-term testing efforts: namely, povetacicept. The company is testing ...

Whether you’re giving or receiving feedback, making it personal isn’t a bad thing—it can help you and your team grow. Fong, a consumer anthropologist and clinical assistant professor of marketing at ...

Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial. The drug, povetacicept, is a central piece of the company's plan to expand into kidney disease. Vertex ...

I’ve had my Shark Rocket HV301 for seven years, and it has never let me down on hardwood floors, high-pile area rugs, or tile. Recently, I moved into a larger apartment with more furniture, more ...

New York Mayor Zohran Mamdani has created a feedback loop in which he excuses or defends radical Islamists and their allies and then exploits their actions to paint himself as a perpetual victim of ...